Domestic Partners

Albert Einstein College of Medicine

Emory University and the Albert Einstein College of Medicine collaborate on the PROBeX study, which examines the pharmacokinetics and the genetic mechanisms of resistance to the TB drug bedaquiline in patients with drug-resistant TB in South Africa. This study will also examine the emergence of resistance to new TB medications in patients with multidrug-resistant (MDR) and extensively drug-resistant tuberculosis (XDR) TB.

DeKalb County Board of Health

The DeKalb County Board of Health serves as a research site for the Emory Tuberculosis Research Unit as well the Tuberculosis Epidemiologic Studies Consortium funded by the Centers for Disease Control and Prevention.

Fulton County Board of Health

Emory investigators collaborate with the Fulton County Board of Health to examine treatment outcomes in patients treated for TB disease in the Atlanta area and evaluate expanded screening programs for latent TB infection.

Texas Biomedical Research Institute

Emory University investigators collaborate with the Texas Biomedical Research Institute in San Antonio, TX on multiple NIH R01 and U19 funded projects on non-human primate models of TB and latent TB infection to understand innate and adaptive immune responses associated with control of TB. The collaboration also examines how HIV perturbs Mycobacterium tuberculosis-specific immunity and the impact of TB and HIV treatment on lung-specific immunity.

University of California San Francisco

Emory investigators collaborate with the University of California San Francisco as part of an NIH-funded Tuberculosis Research Unit (TBRU). The current focus of the TBRU is identifying antigen-specific T-cell responses associated with immunologic control of Mycobacterium tuberculosis infection. Emory also collaborates with UCSF on the Childhood ‘Omics’ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) Study.

University of Pennsylvania

Emory and the University of Pennsylvania collaborate on the Lung function in TB-IRIS (LIFT-IRIS) study, which explores lung inflammation and damage in the context of ART initiation and TB treatment among adults being treated for HIV and TB coinfection.

University of Washington

Emory actively collaborates with the University of Washington on an R01 grant entitled, "The effect of HIV exposure and infection on immunity to TB in children".